2013

  1. Infliximab in paediatric UC

  2. Mesalazine in UC, one or two doses/day

  3. Safety and Tolerability of Low-dose Naltrexone Therapy in Children With Moderate to Severe Crohn’s Disease A Pilot Study

  4. Azathioprine vs conventional therapy in CD

  5. Oral contraceptives, reproductive factors and risk of inflammatory bowel disease

  6. Ulcerative colitis and perfluorooctanoic acid (PFOA) in a highly exposed population of community residents and workers in the mid-Ohio valley

  7. Association Between Depressive Symptoms and Incidence of Crohn’s Disease and Ulcerative Colitis: Results From the Nurses’ Health Study

  8. Body Mass Index and the Risk for Crohn’s Disease and Ulcerative Colitis: Data From a European Prospective Cohort Study (The*IBD*in EPIC Study)